Home » Topics » BioWorld Science

BioWorld Science
RSS

Enrollment ongoing in phase I study of NGM-621

July 29, 2019

Allergan is recruiting participants in phase I/II study of AGN-151587 in patients with LCA10

July 29, 2019

Researchers review the potential of integrating 4D printing with nanomedicine

July 29, 2019

AVPR1A is a new therapeutic target for castration-resistant prostate cancer

July 29, 2019

Inhibrx studies INBRX-101 in patients with alpha1-antitrypsin deficiency in new phase I trial

July 26, 2019

Seattle Genetics begins phase I trial of SGN-CD47M in advanced solid tumors

July 26, 2019

Researchers test nanochannel delivery implant for HIV drug cabotegravir

July 26, 2019

Aptevo advances clinical trials of APVO-210 and APVO-436

July 26, 2019

Abeona announces interim data from phase I/II study of ABO-102 gene therapy for MPS IIIA

July 26, 2019

Phase III OPTIMUM study of ponesimod in relapsing MS meets primary endpoint

July 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...